[Illinois] Bioengineering Seminar Series



Published on


Bioengineering combines the analytical and experimental methods of the engineering profession with the biological and medical sciences to achieve a more detailed understanding of biological phenomena and to develop new techniques and devices. The engineer's quantitative and analytical approach; traditional competence in the processing and control of information, energy, and materials; and ability to design and analyze systems are powerful tools when applied to biology, medicine; and quantitative studies of relationships between biological systems and their environments.

The Illinois Board of Higher Education approved the formation of the Department of Bioengineering on December 9, 2003. Also approved at this time were the granting of Bachelor of Science, Master of Science, and Doctor of Philosophy degrees in Bioengineering.

The first class of 22 undergraduates and 3 graduate students entered in fall 2004.

Currently the Department is home to 10 full-time faculty, 45 graduate students, and over 170 undergraduates.

-From the Dept. of Bioengineering website

Cite this work

Researchers should cite this work as follows:

  • (2013), "[Illinois] Bioengineering Seminar Series," https://nanohub.org/resources/16722.

    BibTex | EndNote


University of Illinois Urbana-Champaign, Urbana, IL


NanoBio Node

University of Illinois at Urbana-Champaign


In This Series

  1. [Illinois] Bioengineering Seminar Series: The Role of Cell Geometry and Adhesion Ligand Presentation in Guiding Stem Cell Differentiation

    26 Nov 2012 | Online Presentations | Contributor(s): Kristopher A. Kilian

    "Substrates that are designed to mimic the extracellular matrix are useful tools for studying cellular processes. Recently, we showed how micropatterning single mesenchymal stem cells can be used to reveal geometric cues that guide lineage specification. Shapes that promote a contractile...

  2. [Illinois] BioEngineering Seminar Series: Novel Receptor-Targeting Radiolabeled Peptides for Cancer Imaging

    26 Nov 2012 | Online Presentations | Contributor(s): Yubin Miao

    Gonadotropin-releasing hormone (GnRH) and melanocortin-1 (MC1) receptors are attractive molecular targets for cancer imaging due to their over-expressions on cancer cells. GnRH and alpha-melanocyte stimulating hormone (α-MSH) peptides can bind the GnRH and MC1 receptors with nanomolar...